Evidence map›Paper›PMID 35736208›Full record

ReviewMarine drugs2022

Progress in Isoindolone Alkaloid Derivatives from Marine Microorganism: Pharmacology, Preparation, and Mechanism.

Sijin Hang, Hui Chen, Wenhui Wu, Shiyi Wang, Yiwen Fang, Ruilong Sheng, Qidong Tu, Ruihua Guo

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Marine drugs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. MarineMarine drugs · 2023
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Sijin HangCollege of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China.
Hui ChenShanghai Engineering Center of Hadal Science and Technology, College of Marine Sciences, Shanghai Ocean University, Shanghai 201306, China.
Wenhui WuCollege of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China.ORCID 0000-0002-1710-8582
Shiyi WangAIEN Institute, Shanghai Ocean University, Shanghai 201306, China.
Yiwen FangDepartment of Chemistry, College of Science, Shantou University, Shantou 515063, China.
Ruilong ShengCQM-Centro de Química da Madeira, Campus da Penteada, Universidade da Madeira, 9000-390 Funchal, Portugal.
Qidong TuJiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang 330013, China.
Ruihua GuoCollege of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China.ORCID 0000-0001-8414-886X
Shanghai Ocean University · CNJiangxi Science and Technology Normal University · CNShanghai Harbour Engineering Design & Research Institute · CNShantou University · CNUniversidade da Madeira · PT

Funding

National Natural Science Foundation of China 81502955National Natural Science Foundation of China 82173731
6 · The paper itself

Abstract

Compound

Indexed as

AlkaloidsFibrinolytic AgentsCerebral InfarctionHumansIsoindolesAlkaloidsFibrinolytic AgentsIsoindol-1-oneIsoindolesFGFC1fibrinolyticStachybotrys longispora FG216Stachybotrys microspora IFO 30018thrombus

Identifiers

PMID35736208
PMCPMC9227046
OpenAlexW4283260595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.